Report cover image

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 193 Pages
SKU # IRE18418429

Description

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2024-2030


The Antivenoms Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 7.17% to reach USD 4.37 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antivenoms Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antivenoms Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..

Market Segmentation & Coverage

This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

Species

Scorpion
  • Snakes
  • Spiders
  • Type

    Monovalent Antivenom
  • Polyvalent Antivenom
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Antivenoms Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antivenoms Market?
    3. What are the technology trends and regulatory frameworks in the Antivenoms Market?
    4. What is the market share of the leading vendors in the Antivenoms Market?
    5. Which modes and strategic moves are suitable for entering the Antivenoms Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    193 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Antivenoms Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Growing incidences of snake bites
    5.1.1.2. Rising awareness of antivenoms available as first-aid
    5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
    5.1.2. Restraints
    5.1.2.1. High production cost of antivenoms
    5.1.3. Opportunities
    5.1.3.1. Technical advancements in antivenoms production
    5.1.3.2. Improvement in distribution networks of antivenoms in countries
    5.1.4. Challenges
    5.1.4.1. Lack of regulatory norms for antivenom manufacturing
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Antivenoms Market, by Species
    6.1. Introduction
    6.2. Scorpion
    6.3. Snakes
    6.4. Spiders
    7. Antivenoms Market, by Type
    7.1. Introduction
    7.2. Monovalent Antivenom
    7.3. Polyvalent Antivenom
    8. Americas Antivenoms Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Antivenoms Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Antivenoms Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. Amsaal LLC
    12.1.2. BB - NCIPD Ltd.
    12.1.3. Bharat Serums and Vaccines Limited (BSV)
    12.1.4. Boehringer Ingelheim International GmbH.
    12.1.5. BTG International Inc.
    12.1.6. Creative BioMart
    12.1.7. CSL
    12.1.8. Haffkine Bio-Pharmaceutical Corporation Ltd.
    12.1.9. Incepta Pharma
    12.1.10. Inosan Biopharma
    12.1.11. Institute of Vaccines and Medical Biologicals
    12.1.12. Instituto Clodomiro Picado
    12.1.13. KM Biologics
    12.1.14. Laboratorios Silanes, S.A. de C.V
    12.1.15. Lexicare Pharma Pvt. Ltd.
    12.1.16. Medtoxin Venom Laboratories, LLC
    12.1.17. Merck & Co., Inc.
    12.1.18. MicroPharm
    12.1.19. Padula Serums Pty Ltd.
    12.1.20. Pfizer Inc.
    12.1.21. Rare Disease Therapeutics, Inc.
    12.1.22. Serum Institute of India Pvt. Ltd.
    12.1.23. Shanghai Serum Bio-technology Co., Ltd.
    12.1.24. VINS Bioproducts Ltd.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
    FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTIVENOMS MARKET DYNAMICS
    FIGURE 7. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
    FIGURE 8. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 10. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us